Printer Friendly

CROSS MEDICAL PRODUCTS ANNOUNCES FDA MARKET CLEARANCE FOR INTEGRAL SCREW SYSTEM

 COLUMBUS, Ohio, May 25 /PRNewswire/ -- Cross Medical Products, Inc., a wholly owned subsidiary of Danninger Medical Technology, Inc. (NASDAQ: DANN), today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market the company's Integral Screw System. This product will be used with the PWB Lumbosacral System, which received 510(k) clearance in April 1992, and significantly expands the market for Cross' spinal devices. It is a more rigid version of the current system.
 Cross Medical Products, Inc. is an innovative developer and marketer of implants and instruments used in the surgical treatment of degenerative diseases of the lumbar (lower) spine. The company is developing additional new products for the PWB Lumbosacral System in order to meet the needs of a wider array of spinal surgeons. It is also working on a new system for spinal deformities such as scoliosis and degenerative disease in the cervical spine. Cross' long-term strategy is to offer implants and instrumentation which can be used in the surgical treatment of all areas of the spine.
 -0- 5/25/93
 /CONTACT: Ira Benson, vice president of Cross Medical Products, Inc., 614-276-8268/
 (DANN)


CO: Cross Medical Products, Inc. ST: Ohio IN: MTC SU: PDT

AR -- CL012 -- 2250 05/25/93 14:55 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 25, 1993
Words:212
Previous Article:NIPSCO INDUSTRIES DECLARES PREFERRED DIVIDENDS
Next Article:AIM 85 REPORTS FIRST QUARTER EARNINGS OF 33 CENTS PER INVESTMENT UNIT
Topics:


Related Articles
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES ADDITION OF TWO KEY MARKETING EXECUTIVES
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES 1992 RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES IMPROVED SECOND QUARTER RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES FDA MARKETING CLEARANCE FOR SHOULDER THERAPY DEVICE
DANNINGER MEDICAL TECHNOLOGY, INC. SUBSIDIARY RECEIVES FDA MARKET CLEARANCE FOR ANTERIOR PORTION OF SYNERGY SYSTEM
DANNINGER MEDICAL TECHNOLOGY SUBSIDIARY RECEIVES FDA MARKET CLEARANCE FOR POSTERIOR PORTION OF SYNERGY SPINAL SYSTEM AND SPINAL PEDICLE SCREWS
DANNINGER MEDICAL TECHNOLOGY, INC. SUBSIDIARY RECEIVES FDA MARKET CLEARANCE FOR THE SYNERGY SPINAL TITANIUM ANTERIOR SPINAL SYSTEM
ST. JUDE MEDICAL ANNOUNCES 11 FDA CLEARANCES IN 1995 FOR PACESETTER LEAD PRODUCTS
QUEST MEDICAL REPORTS FDA CLEARANCE OF 510(K) SUBMISSION FOR THE MPS MYOCARDIAL PROTECTION SYSTEM
Possis Medical Inc. Moves Toward U.S. Marketing Clearance For AngioJet

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters